Colleen L. Lau

Colleen L. Lau

MBBS (UWA), MPHTM (JCU), PhD (UQ), FRACGP, FACTM, FISTM

Infectious Disease Specialist

20+ years of professional experience

Female📍 Acton

About of Colleen L. Lau

Colleen L. Lau is an Infectious Disease Specialist based at 62 Mills Road, Acton, ACT 2601. She helps people who are dealing with infections that can be tricky to work out or hard to manage, especially when symptoms don’t fit the usual pattern.


Over time, infectious diseases can change how a body behaves. Some conditions come from travel, insects, water, or food. Others can show up after time has passed, which is why getting the right diagnosis matters. In many cases, Colleen works with patients and their usual doctors to figure out what’s going on, then plan the next steps in a clear, practical way.


Colleen sees adults and children who need expert advice on a range of infections. This can include things like malaria, dengue fever, Zika virus, chikungunya, and COVID-19. She also looks after people with serious bacterial infections such as typhoid fever, salmonella-related illness, and gonorrhoea. Viral illnesses like hepatitis and measles may also be part of her work, along with illnesses that can affect the brain, such as encephalitis.


She has experience with tropical and travel-related problems too. That can include worm-related infections like helminthiasis, schistosomiasis, and hookworm infection. At times, she helps patients where complications lead to long-term swelling, such as lymphatic filariasis and lymphedema. She also provides guidance in situations involving skin or parasite conditions, including scabies, and infections linked to bites or contaminated environments.


Colleen’s education is strong and wide-ranging. She has an MBBS from UWA, a MPHTM from JCU, and a PhD from UQ. She is also a Fellow of the Royal Australian College of General Practitioners (FRACGP), a Fellow of the Australasian College of Tropical Medicine (FACTM), and a Fellow of the International Society of Travel Medicine (FISTM). That mix helps her connect infectious disease care with everyday clinic reality.


With 20+ years of professional experience, she brings a steady, patient approach. She focuses on careful testing, sensible treatment choices, and follow-up that matches the person’s situation, not just a one-size-fits-all plan. Colleen also contributes to medical research, with publications that support evidence-based care.

Education

  • FRACGP (Fellow, Royal Australian College of General Practitioners)
  • FACTM (Fellow, Australasian College of Tropical Medicine)
  • FISTM (Fellow, International Society of Travel Medicine)

Services & Conditions Treated

HelminthiasisLeptospirosisLymphatic FilariasisLymphedemaSecernentea InfectionsSpirurida InfectionsJapanese EncephalitisTogaviridae DiseaseChikungunyaDengue FeverEncephalitisRabiesScabiesViral Hemorrhagic FeverAngiostrongyliasisAscariasisChildhood VolvulusCOVID-19DistomatosisGonorrheaHepatitisHepatitis AHookworm InfectionHypothyroidismLong Haul COVIDLymphogranuloma VenereumMalariaMeaslesNeonatal HypothyroidismNeonatal SepsisOnchocerciasisParainfluenzaSalmonella EnterocolitisSchistosomiasisSevere Acute Respiratory Syndrome (SARS)SunburnTyphoid FeverWhipworm InfectionYawsZika Virus Disease

Publications

5 total
Spatial prediction of immunity gaps during a pandemic to inform decision making: A geostatistical case study of COVID-19 in Dominican Republic.

Tropical medicine & international health : TM & IH • March 12, 2025

Angela Cadavid Restrepo, Beatris Martin, Helen Mayfield, Cecilia Paulino, Michael De St Aubin, William Duke, Petr Jarolim, Timothy Oasan, Emily Gutiérrez, Ronald Ramm, Devan Dumas, Salome Garnier, Marie Etienne, Farah Peña, Gabriela Abdalla, Beatriz Lopez, Lucia De La Cruz, Bernarda Henriquez, Margaret Baldwin, Adam Kucharski, Benn Sartorius, Eric Nilles, Colleen Lau

Background: To demonstrate the application and utility of geostatistical modelling to provide comprehensive high-resolution understanding of the population's protective immunity during a pandemic and identify pockets with sub-optimal protection. Methods: Using data from a national cross-sectional household survey of 6620 individuals in the Dominican Republic (DR) from June to October 2021, we developed and applied geostatistical regression models to estimate and predict Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) spike (anti-S) antibodies (Ab) seroprevalence at high resolution (1 km) across heterogeneous areas. Results: Spatial patterns in population immunity to SARS-CoV-2 varied across the DR. In urban areas, a one-unit increase in the number of primary healthcare units per population and 1% increase in the proportion of the population aged under 20 years were associated with higher odds ratios of being anti-S Ab positive of 1.38 (95% confidence interval [CI]: 1.35-1.39) and 1.35 (95% CI: 1.32-1.33), respectively. In rural areas, higher odds of anti-S Ab positivity, 1.45 (95% CI: 1.39-1.51), were observed with increasing temperature in the hottest month (per°C), and 1.51 (95% CI: 1.43-1.60) with increasing precipitation in the wettest month (per mm). Conclusions: A geostatistical model that integrates contextually important socioeconomic and environmental factors can be used to create robust and reliable predictive maps of immune protection during a pandemic at high spatial resolution and will assist in the identification of highly vulnerable areas.

The epidemiology of hospitalisations from four key environmentally sensitive zoonotic diseases in Queensland, 2012-2019.

Tropical Medicine & International Health : TM & IH • June 17, 2025

Tatiana Proboste, Colleen Lau, Nicholas Clark, Paul Jagals, Peter Sly, Stephen Lambert, Gregor Devine, Guido Zuccon, Ricardo Soares MagalhĂŁes

Zoonotic diseases whose transmission processes are sensitive to environmental characteristics represent an important public health burden in Australia, particularly in Queensland. This study aimed to analyse the epidemiology of hospitalisations from the four main environmental zoonotic diseases-leptospirosis, melioidosis, Q fever, and Ross River virus-from 2012 to 2019 in Queensland. Our analyses reveal an increasing trend of hospitalisation incidence for melioidosis, stable incidence for Q fever and Ross River virus infection, and a declining trend for leptospirosis. We identified sex and age disparities in hospitalisations, with males being more likely to be hospitalised for leptospirosis, melioidosis, and Q fever compared to females. We also uncovered discrepancies between hospitalisation and notification data, which could be attributed to diagnostic and reporting criteria. The findings of this study show that the epidemiological patterns of hospitalisation are different to the notification for the same diseases and underscore the importance of accurate recording and reporting of zoonoses-related hospitalisations to inform environmental public health interventions.

The future of spatial epidemiology in the AI era: enhancing machine learning approaches with explicit spatial structure.

Geospatial Health • March 11, 2025

Nima Kianfar, Benn Sartorius, Colleen Lau, Robert Bergquist, Behzad Kiani

Spatial epidemiology, defined as the study of spatial patterns in disease burdens or health outcomes, aims to estimate disease risk or incidence by identifying geographical risk factors and populations at risk (Morrison et al., 2024). Research in spatial epidemiology relies on both conventional approaches and Machine- Learning (ML) algorithms to explore geographic patterns of diseases and identify influential factors (Pfeiffer & Stevens, 2015). Traditional spatial techniques, including spatial autocorrelation using global Moran's I, Geary's C (Amgalan et al., 2022), and Ripley's K Function (Kan et al., 2022), Local Indicators of Spatial Association (LISA) (Sansuk et al., 2023), hotspot analysis by Getis-Ord Gi* (Lun et al., 2022), spatial lag models (Rey & Franklin, 2022), and Geographically Weighted Regression (GWR) (Kiani et al., 2024) are designed to explicitly incorporate the spatial structure of data into spatial modelling, often referred to as spatially aware models (Reich et al., 2021). Beyond these models, several other spatially aware approaches that have been widely applied in epidemiological studies include but are not limited to Bayesian spatial models that account for spatial uncertainty in disease mapping, such as Bayesian Hierarchical models, Conditional Autoregressive (CAR), and Besage, York, and Mollie' (BYM) models (Louzada et al., 2021). Bayesian methods are statistically rigorous techniques that assume neighboring regions share similar values. Kulldorff's Spatial Scan Statistic is another traditional spatial technique that uses a moving circular window to extract significant disease clusters (Tango, 2021). Moreover, geostatistical models such as Kriging and Inverse Distance Weighting (IDW) allow for continuous spatial interpolation of health data (Nayak et al., 2021). [...].

Geospatial analysis of leptospirosis clusters and risk factors in two provinces of the Dominican Republic.

PLoS Neglected Tropical Diseases • March 02, 2025

Beatris Martin, Benn Sartorius, Helen Mayfield, Angela Cadavid Restrepo, Behzad Kiani, Cecilia Then Paulino, Marie Etienne, Ronald Skewes Ramm, Michael De St Aubin, Devan Dumas, Salomé Garnier, William Duke, Farah Peña, Gabriela Abdalla, Lucia De La Cruz, Bernarda Henríquez, Margaret Baldwin, Adam Kucharski, Eric Nilles, Colleen Lau

Background: Drivers of leptospirosis transmission can vary across regions, leading to spatial clustering of infections. This study aims to identify clusters of leptospirosis seroprevalence in the Dominican Republic (DR) and factors associated with high-risk areas. Results: We analysed data from two provinces, Espaillat and San Pedro de Macoris (SPM), obtained on a national survey conducted in 2021 (n = 2,078). Samples were tested by microscopic agglutination testing (MAT) to detect leptospirosis antibodies. We used flexible spatial scan statistics to locate significant clusters for seropositive individuals (all serogroups combined) in each province and calculated risk ratios (RR) at the household and community level. Environmental and sociodemographic risk factors associated with clusters were assessed by logistic regression. One cluster was identified in each province. Participants living inside a cluster were more likely to live further from health facilities (OR 1.86, p < 0.001 and OR 4.41, p = 0.044 by motorized travel time in Espaillat and SPM, respectively). Cluster participants were also less likely to live in areas of higher population density (OR 0.76, p < 0.01 and OR 0.29, p < 0.001 in Espaillat and SPM, respectively) and in communities with higher gross domestic product (GDP) (OR 0.70, p < 0.001 and OR 0.42, p < 0.001 in Espaillat and SPM, respectively). Additional risk factors varied between Espaillat and SPM. Conclusions: Our findings confirm the clustered spatial pattern of leptospirosis and highlight that transmission drivers vary by province. While both provinces show higher transmission in impoverished areas, modifiable factors differ, requiring tailored public health interventions.

A study protocol for developing a spatial vulnerability index for infectious diseases of poverty in the Caribbean region.

Global Health Action • February 11, 2025

Behzad Kiani, Beatris Mario Martin, Angela Cadavid Restrepo, Helen Mayfield, Eloise Skinner, Ana Karina Maldonado AlcaĂ­no, Eric Nilles, Colleen Lau, Benn Sartorius

Infectious diseases of poverty (IDoP) affect disproportionately resource-limited and marginalized populations, resulting in spatial patterns of vulnerability across various geographical areas. Currently, no spatial indices exist to quantify vulnerability to IDoP at a fine geographical level within countries, such as municipalities or provinces. Without such an index, policymakers cannot effectively allocate resources or target interventions in the most vulnerable areas. This protocol aims to specify a methodological approach to measure spatial variation in vulnerability to IDoP. We will evaluate this methodological approach using surveillance and seroprevalence data from the Dominican Republic (DR) as part of a broader effort to develop a regional index for the Caribbean region. The study will consist of three main components. The first component involves identifying the relevant factors associated with IDoP in the Caribbean region through a scoping review, supplemented by expert-elicited opinion. The second component will apply a Fuzzy Analytic Hierarchy Process to weigh the aforementioned factors and develop a spatial composite index, using open data and available national surveys in the DR. In the final component, we will evaluate and validate the index by analysing the prevalence of at least three IDoPs at a fine-grained municipal level in the DR, using seroprevalence data from a 2021 national field study and other national surveillance programs. The spatial vulnerability index framework developed in this study will assess the degree of vulnerability to IDoP across different geographical scales, depending on data availability in each country.

Frequently Asked Questions

What services does Dr Colleen L. Lau offer?
Dr Colleen L. Lau provides a range of infectious disease services including helminthiasis, leptospirosis, various parasitic infections, viral illnesses such as dengue and Zika, malaria, measles, hepatitis, respiratory infections, and conditions like long haul COVID and lymphedema. She also treats conditions such as scabies and gonorrhea.
What conditions does she treat?
Her focus is infectious diseases and related conditions, including travel-related infections, viral and bacterial infections, emerging diseases, and complications like lymphedema. Specific examples from her listed services include dengue fever, malaria, hepatitis, Zika virus disease, scabies, and measles.
Where is Dr Lau’s clinic located?
Her practice is at 62 Mills Road, Acton, ACT 2601, Australia.
How can I book an appointment?
For booking, please contact the clinic directly. Appointments are arranged through the practice’s usual scheduling process.
Is she specialised in travel medicine or tropical diseases?
Yes. Dr Lau holds Fellowships in tropical medicine and travel medicine and has extensive experience in travel-related infectious diseases.
What qualifications does Dr Lau have?
She holds MBBS from UWA, MPHTM from JCU, PhD from UQ, and fellowships FRACGP, FACTM, and FISTM, reflecting broad expertise in general practice, tropical medicine, and travel medicine.